Gufic Biosciences Limited

445.55

INR
+8.05(+1.84%)
As of November 14, 2024 10:00:00 AM

Gufic Biosciences Limited Share Price Information

24 hour Low and High

Low: 438.15
High: 452

All time High

485.45

Price Change 1h

+₹7.40 +1.69%

Price Change 1d

+₹7.40 +1.69%

Price Change 1w

+₹-28.00 +-5.91%

Gufic Biosciences Limited Market Information

Exchange

NSE

Market Cap

4402.71 Cr

About Gufic Biosciences Limited Share

Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, South America, and internationally. It manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs) segments. In addition, the company offers criti care, criticare life, ferticare, and spark pharmaceutical products; and herbal, aesthaderm, gufic stridden, and personal care products. It supplies its products to hospital chains and medical facilities. The company was founded in 1970 and is based in Mumbai, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

1491

CEO

Mr. Pranav Jayesh Choksi

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • There's Reason For Concern Over Gufic Biosciences Limited's (NSE:GUFICBIO) Massive 26% Price Jump
  • Gufic Biosciences Limited's (NSE:GUFICBIO) most bullish insider, Top Key Executive Jayesh Choksi must be pleased with the recent 14% gain
  • Gufic Bio Consolidated June 2024 Net Sales at Rs 202.81 crore, up 4% Y-o-Y
  • Gufic BioSciences Stock Surges 8.0% and Reaches New Highs on Strong Market Performance
  • Top Experts Bet Big On Pharma Stocks: How U.S. Recovery Fuels The Surge?

FAQs

Gufic Biosciences Limited

445.55

INR
+8.05(+1.84%)
As of November 14, 2024 10:00:00 AM

Gufic Biosciences Limited Share Price Information

24 hour Low and High

Low: 438.15
High: 452

All time High

485.45

Price Change 1h

+₹7.40 +1.69%

Price Change 1d

+₹7.40 +1.69%

Price Change 1w

+₹-28.00 +-5.91%

Gufic Biosciences Limited Market Information

Exchange

NSE

Market Cap

4402.71 Cr

About Gufic Biosciences Limited Share

Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, South America, and internationally. It manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs) segments. In addition, the company offers criti care, criticare life, ferticare, and spark pharmaceutical products; and herbal, aesthaderm, gufic stridden, and personal care products. It supplies its products to hospital chains and medical facilities. The company was founded in 1970 and is based in Mumbai, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

1491

CEO

Mr. Pranav Jayesh Choksi

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • There's Reason For Concern Over Gufic Biosciences Limited's (NSE:GUFICBIO) Massive 26% Price Jump
  • Gufic Biosciences Limited's (NSE:GUFICBIO) most bullish insider, Top Key Executive Jayesh Choksi must be pleased with the recent 14% gain
  • Gufic Bio Consolidated June 2024 Net Sales at Rs 202.81 crore, up 4% Y-o-Y
  • Gufic BioSciences Stock Surges 8.0% and Reaches New Highs on Strong Market Performance
  • Top Experts Bet Big On Pharma Stocks: How U.S. Recovery Fuels The Surge?

FAQs